Intracellular Expression of CTB in Vibrio cholerae Strains in Laboratory Culture Conditions
- PMID: 37072680
- PMCID: PMC10331945
- DOI: 10.4014/jmb.2302.02014
Intracellular Expression of CTB in Vibrio cholerae Strains in Laboratory Culture Conditions
Abstract
The introduction of the toxT-139F allele triggers the expression of TCP (toxin co-regulated pilus) and CT (cholera toxin) under simple laboratory culture conditions in most Vibrio cholerae strains. Such V. cholerae strains, especially strains that have been used in OCVs (oral cholera vaccines), can induce antibody responses against TCP in animal models. However, CT produced in these V. cholerae strains is secreted into the culture medium. In this study, V. cholerae strains that can express intracellular CTB under the control of the toxT-139F allele have been constructed for potential application in OCVs. First, we constructed a recombinant plasmid directly linking the ctxAB promoter to ctxB without ctxA and confirmed CTB expression from the plasmid in V. cholerae containing the toxT-139F allele. We constructed another recombinant plasmid to express NtrCTB, from which 14 internal amino acids-from the 7th to the 20th amino acid-of the leader peptide of CTB have been omitted, and we found that NtrCTB remained in the cells. Based on those results, we constructed V. cholerae strains in which chromosomal ctxAB is replaced by ntrctxB or ntrctxB-dimer. Both NtrCTB and NtrCTB-dimer remained in the bacterial cells, and 60% of the NtrCTB-dimer in the bacterial cells was maintained in a soluble form. To develop improved OCVs, these strains could be tested to see whether they induce immune responses against CTB in animal models.
Keywords: Cholera; Vibrio cholerae; cholera toxin (CT); cholera toxin B subunit (CTB); vaccine.
Conflict of interest statement
The authors have no financial conflicts of interest to declare.
Figures





Similar articles
-
Inactivated Vibrio cholerae Strains That Express TcpA via the toxT-139F Allele Induce Antibody Responses against TcpA.J Microbiol Biotechnol. 2022 Nov 28;32(11):1396-1405. doi: 10.4014/jmb.2209.09001. Epub 2022 Oct 12. J Microbiol Biotechnol. 2022. PMID: 36317425 Free PMC article.
-
Novel Cholera Toxin Variant and ToxT Regulon in Environmental Vibrio mimicus Isolates: Potential Resources for the Evolution of Vibrio cholerae Hybrid Strains.Appl Environ Microbiol. 2019 Jan 23;85(3):e01977-18. doi: 10.1128/AEM.01977-18. Print 2019 Feb 1. Appl Environ Microbiol. 2019. PMID: 30446560 Free PMC article.
-
Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.Vaccine. 2008 Oct 9;26(43):5443-8. doi: 10.1016/j.vaccine.2008.05.088. Epub 2008 Jun 26. Vaccine. 2008. PMID: 18582519 Free PMC article.
-
Genetics of cholera toxin.Indian J Med Res. 1992 Jul;95:163-7. Indian J Med Res. 1992. PMID: 1398801 Review.
-
Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes.Expert Opin Ther Targets. 2024 Jul;28(7):623-635. doi: 10.1080/14728222.2024.2369622. Epub 2024 Jul 19. Expert Opin Ther Targets. 2024. PMID: 39028535 Review.
Cited by
-
Variations in the Antivirulence Effects of Fatty Acids and Virstatin against Vibrio cholerae Strains.J Microbiol Biotechnol. 2024 Sep 28;34(9):1757-1768. doi: 10.4014/jmb.2405.05002. Epub 2024 Jul 19. J Microbiol Biotechnol. 2024. PMID: 39187456 Free PMC article.